IRIS
RUSCITTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.519
EU - Europa 3.662
AS - Asia 2.724
SA - Sud America 361
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 12.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.484
IE - Irlanda 1.394
SG - Singapore 1.179
CN - Cina 701
RU - Federazione Russa 611
HK - Hong Kong 420
IT - Italia 360
SE - Svezia 337
BR - Brasile 327
TR - Turchia 298
DE - Germania 290
UA - Ucraina 222
GB - Regno Unito 131
FI - Finlandia 109
FR - Francia 72
BE - Belgio 45
IN - India 35
VN - Vietnam 30
CZ - Repubblica Ceca 23
CA - Canada 19
NL - Olanda 16
AR - Argentina 12
ZA - Sudafrica 10
EU - Europa 9
MX - Messico 9
CH - Svizzera 7
EC - Ecuador 7
GR - Grecia 7
IQ - Iraq 7
AT - Austria 6
LT - Lituania 6
RO - Romania 6
UZ - Uzbekistan 6
AU - Australia 5
AZ - Azerbaigian 5
VE - Venezuela 5
DZ - Algeria 4
ID - Indonesia 4
KZ - Kazakistan 4
LU - Lussemburgo 4
PK - Pakistan 4
BD - Bangladesh 3
CO - Colombia 3
DK - Danimarca 3
ES - Italia 3
IL - Israele 3
JO - Giordania 3
MA - Marocco 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
MD - Moldavia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
TW - Taiwan 1
UY - Uruguay 1
Totale 12.310
Salva come PNG Salva come JPEG
Città #
Dublin 1.391
Chandler 1.137
Jacksonville 942
Singapore 548
Santa Clara 489
Hong Kong 418
Boardman 386
New York 224
Izmir 208
Ashburn 163
Lawrence 161
Princeton 161
Ann Arbor 151
Moscow 140
Nanjing 125
Wilmington 123
Beijing 104
L'aquila 99
San Mateo 83
Los Angeles 67
Dearborn 63
L’Aquila 56
Woodbridge 55
Helsinki 50
Nanchang 50
Milan 47
Brussels 41
Shanghai 37
Council Bluffs 32
Seattle 32
Dallas 31
Dong Ket 30
Mountain View 30
Shenyang 30
Kunming 29
Des Moines 28
Hebei 24
Pescara 23
Tianjin 22
Jinan 21
Brno 20
Jiaxing 19
Kitzingen 19
São Paulo 19
Verona 19
Cedar Knolls 17
Changsha 17
Munich 17
Zhengzhou 17
Pune 16
Rio de Janeiro 16
Falkenstein 15
Frankfurt am Main 15
Guangzhou 15
Houston 15
Hefei 12
Lappeenranta 12
Ningbo 12
Norwalk 12
Belo Horizonte 11
Bremen 11
Hangzhou 11
Washington 11
Amsterdam 9
Philadelphia 9
Rome 9
Stockholm 9
Assago 8
Grafing 8
Chengdu 7
Edinburgh 7
Porto Alegre 7
Changchun 6
Ottawa 6
Quito 6
Redwood City 6
Brasília 5
Fremont 5
Guarulhos 5
Johannesburg 5
Lanzhou 5
London 5
Mumbai 5
Phoenix 5
Tashkent 5
Toronto 5
Zurich 5
Baghdad 4
Baku 4
Berlin 4
Caxias do Sul 4
Goiânia 4
Istanbul 4
Ivanovo 4
Jinhua 4
Leuven 4
New Delhi 4
Ponte A Égola 4
St Petersburg 4
Taizhou 4
Totale 8.403
Salva come PNG Salva come JPEG
Nome #
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 128
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 115
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 113
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 113
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 108
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 106
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 106
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 106
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 104
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 104
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 104
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 104
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 103
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 102
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 97
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 95
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 92
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 92
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 91
Cardiovascular disease in primary sjögren’s syndrome 91
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 90
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 90
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 90
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 90
Stem cell therapies for systemic sclerosis 89
A comprehensive review on adult onset Still's disease 88
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 87
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 87
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 86
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 85
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 85
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 84
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 84
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 83
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 83
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 82
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 81
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 81
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 81
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 81
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 81
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 81
Interstitial lung disease in systemic sclerosis: current and future treatment. 79
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 78
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 77
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 76
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 76
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 75
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 75
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 73
Computed Tomography and MR Imaging in Rheumatoid Arthritis 73
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 73
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 73
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 72
Methotrexate: an old new drug in autoimmune disease. 71
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 71
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 70
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 70
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 70
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 70
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 69
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 69
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 68
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 68
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 68
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 68
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 68
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 67
Tocilizumab for the treatment of adult-onset Still's disease: Results from a case series 67
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 67
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 66
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 66
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 65
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 65
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 65
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 65
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 65
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 64
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 64
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 63
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 63
Angiogenic cytokines and growth factors in systemic sclerosis. 62
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 62
Diagnostic and interventional radiology fundamentals of synovial pathology 62
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 62
The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review 62
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders 61
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis 61
The Vessels Contribute to Fibrosis in Systemic Sclerosis 61
POTENTIAL OF STEM CELLS IN THE TREATMENT OF RHEUMATIC DIDEASE 60
IL LABORATORIO IN REUMATOLOGIA 60
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 59
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 59
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 59
IL-9 over-expression and Th9 polarization in Systemic Sclerosis patients 58
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 58
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 58
Il laboratorio nelle malattie reumatiche 57
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 57
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 57
Totale 7.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020377 0 0 0 0 0 0 0 0 129 61 22 165
2020/20211.193 31 132 23 155 155 48 157 21 153 44 206 68
2021/2022803 39 24 153 63 17 12 31 42 66 44 61 251
2022/20233.501 226 193 60 362 209 328 49 217 1.676 21 119 41
2023/20241.043 117 46 69 99 76 325 31 54 22 59 41 104
2024/20253.886 118 79 404 213 624 449 575 308 1.116 0 0 0
Totale 12.652